HCM
Price
$14.58
Change
-$0.16 (-1.09%)
Updated
Oct 21, 12:37 PM (EDT)
Capitalization
2.56B
23 days until earnings call
Intraday BUY SELL Signals
KURE
Price
$18.20
Change
+$0.02 (+0.11%)
Updated
Oct 21, 10:53 AM (EDT)
Net Assets
111.47M
Intraday BUY SELL Signals
Interact to see
Advertisement

HCM vs KURE

HCM vs KURE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HCM vs. KURE commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCM is a StrongBuy and KURE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HCM with price predictions
Oct 20, 2026

HCM sees its Stochastic Oscillator ascends from oversold territory

On October 16, 2026, the Stochastic Oscillator for HCM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 70 instances where the indicator left the oversold zone. In 56 of the 70 cases the stock moved higher in the following days. This puts the odds of a move higher at over 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on HCM as a result. In 65 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The 50-day moving average for HCM moved above the 200-day moving average on October 14, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +4.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCM advanced for three days, in 197 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

HCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 128 of 185 cases where HCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HCM turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 40 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. HCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.032) is normal, around the industry mean (10.819). HCM has a moderately high P/E Ratio (147.400) as compared to the industry average of (-7.131). Projected Growth (PEG Ratio) (4.030) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (4.268) is also within normal values, averaging (178.797).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for KURE with price predictions
Oct 20, 2026

Momentum Indicator for KURE turns negative, indicating new downward trend

KURE saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 72 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for KURE turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 40 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

KURE moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KURE crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where KURE advanced for three days, in 221 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

KURE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 158 of 187 cases where KURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

FUNDAMENTALS RATINGS
HCM: Fundamental Ratings
HCM
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HCMKURE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (HCM: $14.74)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCM’s FA Score shows that 1 FA rating(s) are green while .

  • HCM’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCM’s TA Score shows that 6 TA indicator(s) are bullish.

  • HCM’s TA Score: 6 bullish, 2 bearish.

Price Growth

HCM (@Pharmaceuticals: Generic) experienced а +9.19% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.39%. For the same industry, the average monthly price growth was -7.09%, and the average quarterly price growth was +9.61%.

Reported Earning Dates

HCM is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.39% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
HCM
Daily Signal:
Gain/Loss:
KURE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WDIV82.190.58
+0.71%
State Street SPDR S&P Global Dividend ETF (WDIV)
BUFC43.500.10
+0.23%
AB Conservative Buffer ETF (BUFC)
VBCA75.39N/A
+0.01%
Vanguard Target Maturity 2027 Corporate Bond ETF (VBCA)
GSX31.16N/A
N/A
Tradr 2X Long GS Daily ETF
CPNQ27.91N/A
-0.01%
Calamos Nasdaq-100 Structured Alt Protection ETF - December (CPNQ)

KURE and

Correlation & Price change

A.I.dvisor tells us that KURE and LEGN have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KURE and LEGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURE
1D Price
Change %
KURE100%
+3.00%
LEGN - KURE
4%
Poorly correlated
+1.93%
BNR - KURE
2%
Poorly correlated
+2.77%
NBP - KURE
-0%
Poorly correlated
+9.62%
HCM - KURE
-2%
Poorly correlated
+3.95%
ONC - KURE
-2%
Poorly correlated
+3.87%
More